
New research on sugar-coated nanoparticles shows a promising mRNA-delivery strategy aimed at treating aggressive brain tumors, inviting readers to learn about the approach and its potential implications.
Key Takeaways
- Sugar-coated lipid nanoparticles delivered therapeutic mRNA across the blood-brain barrier in mice
- Treatment restored a tumor-suppressing protein and reduced glioblastoma tumor size in mice
- Treated mice showed a 50% increase in median survival without noticeable organ damage
